|
| | Publication Year | Title | Author(s) |
| 81 | 2023 | Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo. | Wichmann, Christian W; Poniger, Stan ; Guo, Nancy; Roselt, Peter; Rudd, Stacey E; Donnelly, Paul S; Blyth, Benjamin; Van Zuylekom, Jessica; Rigopoulos, Angela; Burvenich, Ingrid J G; Morandeau, Laurence; Mohamed, Shifaza; Nowak, Anna K; Hegi-Johnson, Fiona; MacManus, Michael; Scott, Andrew M |
| 82 | 2023 | 3D printed patient-specific prostate cancer models to guide nerve-sparing robot-assisted radical prostatectomy: a systematic review. | Coles-Black, Jasamine ; Ong, Sean; Teh, Jiasian ; Kearns, Paul; Ischia, Joseph J ; Bolton, Damien M ; Lawrentschuk, Nathan |
| 83 | 2023 | 18F-labeling and initial in vivo evaluation of a Hitomi peptide for imaging tissue transglutaminase 2. | Ackermann, Uwe ; Jäger, Luise; Rigopoulos, Angela; Burvenich, Ingrid Julienne Georgette; O'Keefe, Graeme Joseph; Scott, Andrew M |
| 84 | 2023 | Editorial: Overcoming drug relapse and therapy resistance in NSCLC. | Parakh, Sagun ; Leong, Tracy L ; Best, Sarah A; Poh, Ashleigh R |
| 85 | 2023 | Spatially Characterizing the Immune Contexture in Mouse Tissue Using Multiplex Immunohistochemistry. | Pang, Lokman; Ernst, Matthias ; Huynh, Jennifer |
| 86 | 20-Dec-2022 | Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors. | Lopci, E; Aide, N; Dimitrakopoulou-Strauss, A; Dercle, L; Iravani, A; Seban, R D; Sachpekidis, C; Humbert, O; Gheysens, O; Glaudemans, A W J M; Weber, W A; Van den Abbeele, A D; Wahl, R L; Scott, Andrew M ; Pandit-Taskar, N; Hicks, R J |
| 87 | 17-Dec-2022 | Tumor Growth Remains Refractory to Myc Ablation in Host Macrophages. | Morrow, Riley J; Allam, Amr H; Konecnik, Josh; Baloyan, David; Dijkstra, Christine ; Eissmann, Moritz F ; Jacob, Saumya P; O'Brien, Megan; Poh, Ashleigh R; Ernst, Matthias |
| 88 | 17-Dec-2022 | Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers. | Halkett, Georgia K B; Breen, Lauren J; Berg, Melissa; Sampson, Rebecca; Sim, Hao-Wen; Gan, Hui K ; Kong, Benjamin Y; Nowak, Anna K; Day, Bryan W; Harrup, Rosemary; James, Melissa; Saran, Frank; Mcfarlane, Brett; Tse, Chris; Koh, Eng-Siew |
| 89 | 18-Nov-2022 | ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol. | Hegi-Johnson, Fiona; Rudd, Stacey E; Wichmann, Christian; Akhurst, Tim; Roselt, Peter; Trinh, Jenny; John, Thomas ; Devereux, Lisa; Donnelly, Paul S; Hicks, Rod; Scott, Andrew M ; Steinfort, Daniel; Fox, Stephen; Blyth, Benjamin; Parakh, Sagun ; Hanna, Gerard G; Callahan, Jason; Burbury, Kate; MacManus, Michael |
| 90 | 10-Nov-2022 | Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy. | Cao, Zhipeng; Burvenich, Ingrid J; Zhao, Kening; Senko, Clare ; Glab, Jason; Fogliaro, Renee; Liu, Zhanqi; Jose, Irvin; Puthalakath, Hamsa; Hoogenraad, Nick J; Osellame, Laura D; Scott, Andrew M |
| 91 | Nov-2022 | PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial. | Buteau, James P; Martin, Andrew J; Emmett, Louise; Iravani, Amir; Sandhu, Shahneen; Joshua, Anthony M; Francis, Roslyn J; Zhang, Alison Y; Scott, Andrew M ; Lee, Sze Ting ; Azad, Arun A; McJannett, Margaret M; Stockler, Martin R; Williams, Scott G; Davis, Ian D; Hofman, Michael S |
| 92 | Nov-2022 | Microbeam Radiation Therapy Controls Local Growth of Radioresistant Melanoma and Treats Out-of-Field Locoregional Metastasis. | Trappetti, Verdiana; Potez, Marine; Fernandez-Palomo, Cristian; Volarevic, Vladislav; Shintani, Nahoko; Pellicioli, Paolo; Ernst, Alexander; Haberthür, David; Fazzari, Jennifer M; Krisch, Michael; Laissue, Jean A; Anderson, Robin L ; Martin, Olga A; Djonov, Valentin G |
| 93 | 11-Oct-2022 | Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and metastasis. | Poh, Ashleigh R; O'Brien, Megan; Chisanga, David; He, Hong ; Baloyan, David; Traichel, Jasmin; Dijkstra, Christine ; Chopin, Michaël; Nutt, Stephen; Whitehead, Lachlan; Boon, Louis; Parkin, Ashleigh; Lowell, Clifford; Pajic, Marina; Shi, Wei; Nikfarjam, Mehrdad ; Ernst, Matthias |
| 94 | 1-Oct-2022 | Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX. | van Dijk, Erik; van Werkhoven, Erik; Asher, Rebecca; Mooi, Jennifer K ; Espinoza, David; van Essen, Hendrik F; van Tinteren, Harm; van Grieken, Nicole C T; Punt, Cornelis J A; Tebbutt, Niall C ; Ylstra, Bauke |
| 95 | Oct-2022 | Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance. | Hapgood, Greg; Latimer, Maya; Lee, Sze Ting ; Kuss, Bryone; Lade, Stephen; Tobin, Joshua W D; Purtill, Duncan; Campbell, Belinda A; Prince, H Miles; Hawkes, Eliza A ; Shortt, Jake; Radeski, Dejan |
| 96 | Oct-2022 | Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma. | Udovicich, Cristian; Callahan, Jason; Bressel, Mathias; Ong, Wee Loon ; Perera, Marlon ; Tran, Ben; Azad, Arun; Haran, Shankar; Moon, Daniel; Chander, Sarat; Shaw, Mark; Eapen, Renu S ; Goad, Jeremy; Lawrentschuk, Nathan; Murphy, Declan G; Hofman, Michael; Siva, Shankar |
| 97 | Oct-2022 | Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer. | Augustine, Titto; John, Peter; Friedman, Tyler; Jiffry, Jeeshan; Guzik, Hillary; Mannan, Rifat; Gupta, Riya; Delano, Catherine; Mariadason, John M ; Zang, Xingxing; Maitra, Radhashree; Goel, Sanjay |
| 98 | 14-Sep-2022 | Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma. | Kong, Benjamin Y; Sim, Hao-Wen; Barnes, Elizabeth H; Nowak, Anna K; Hovey, Elizabeth J; Jeffree, Rosalind; Harrup, Rosemary; Parkinson, Jonathon; Gan, Hui K ; Pinkham, Mark B; Yip, Sonia; Hall, Merryn; Tu, Emily; Carter, Candace; Koh, Eng-Siew; Lwin, Zarnie; Dowling, Anthony; Simes, John S; Gedye, Craig |
| 99 | 8-Sep-2022 | Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss. | Mejía-Hernández, Javier Octavio; Keam, Simon P; Saleh, Reem; Muntz, Fenella; Fox, Stephen B; Byrne, David; Kogan, Arielle; Pang, Lokman; Huynh, Jennifer; Litchfield, Cassandra; Caramia, Franco; Lozano, Guillermina; He, Hua; You, James M; Sandhu, Shahneen; Williams, Scott G; Haupt, Ygal; Haupt, Sue |
| 100 | Sep-2022 | Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving Steroid Receptor Coactivator Signaling in Gastric Cancer. | Zhang, Xing; Soutto, Mohammed; Chen, Zheng; Bhat, Nadeem; Zhu, Shoumin; Eissmann, Moritz F ; Ernst, Matthias ; Lu, Heng; Peng, Dunfa; Xu, Zekuan; El-Rifai, Wael |
